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Two small GTPase Rabs, Rab32 and Rab38, have recently been proposed to regulate trafficking of melanogenic enzymes
to melanosomes in mammalian epidermal melanocytes; however, the exact molecular mechanism of Rab32/38-mediated
transport of melanogenic enzymes has never been clarified, because no Rab32/38-specific effector has ever been identified.
In this study, we screened for a Rab32/38-specific effector by a yeast two-hybrid assay using a guanosine triphosphate
(GTP)-locked Rab32/38 as bait and found that VPS9-ankyrin-repeat protein (Varp)/Ankrd27, characterized previously as
a guanine nucleotide exchange factor (GEF) for Rab21, functions as a specific Rab32/38-binding protein in mouse
melanocyte cell line melan-a. Deletion analysis showed that the first ankyrin-repeat (ANKR1) domain functions as a
GTP-dependent Rab32/38-binding domain, but that the N-terminal VPS9 domain (i.e., Rab21-GEF domain) does not.
Small interfering RNA-mediated knockdown of endogenous Varp in melan-a cells caused a dramatic reduction in Tyrp1
(tyrosinase-related protein 1) signals from melanosomes but did not cause any reduction in Pmel17 signals. Furthermore,
expression of the ANKR1 domain in melan-a cells also caused a dramatic reduction of Tyrp1 signals, whereas the VPS9
domain had no effect. Based on these findings, we propose that Varp functions as the Rab32/38 effector that controls
trafficking of Tyrp1 in melanocytes.
INTRODUCTION
Melanosomes are specialized organelles that synthesize and
store melanin pigments in pigment cells. The same as other
organelles, a variety of membrane trafficking events are
involved in the formation, maturation, and transport of
melanosomes; thus, melanosomes are considered a good
model system for analyzing organelle formation and trans-
port (reviewed in Marks and Seabra, 2001; Raposo and
Marks, 2007). Several distinct Rab-type small GTPases,
which are conserved membrane trafficking proteins in all
eukaryotic cells (reviewed in Pfeffer, 2001; Zerial and
McBride, 2001), have been shown to be involved in the
maturation and transport of melanosomes in mammalian
epidermal melanocytes.
In general, Rab functions as a molecular switch by cycling
between a guanosine diphosphate (GDP)-bound state and a
GTP-bound state, and the GTP-bound active form promotes
membrane traffic through interaction with a specific effector
molecule (Grosshans et al., 2006; Schwartz et al., 2007). The
best characterized Rab isoform in melanocytes is Rab27A,
which is involved in melanosome transfer from microtu-
bules to actin filaments through interaction with the mela-
nocyte-specific effector Slac2-a/melanophilin (Fukuda et al.,
2002; Wu et al., 2002; Kuroda et al., 2003; Hume et al., 2006;
reviewed in Fukuda, 2005) and melanosome anchoring to
the plasma membrane through interaction with another
Rab27A effector, Slp2-a (Kuroda and Fukuda, 2004). Thus,
dysfunctions of Rab27A cause pigment dilution in human
type II Griscelli syndrome patients (Ménasché et al., 2000)
and diluted coat color of the mouse ashen (Wilson et al., 2000)
because of a defect in melanosome transport.
The diluted coat color of another mouse mutant, chocolate,
has recently been shown to be caused by dysfunctions of
Rab38, and targeting of tyrosinase-related protein 1 (Tyrp1)
to melanosomes is impaired in chocolate melanocytes (Loftus
et al., 2002). Rab38 is also involved in the trafficking of
another melanogenic enzyme, tyrosinase, to melanosomes in
skin melanocytes (Wasmeier et al., 2006) and to immature
melanosomes in retinal pigment epithelial cells (Lopes et al.,
2007). In addition, Rab32, a closely related isoform of Rab38,
can compensate for the function of Rab38 in the trafficking of
melanogenic enzymes in melanocytes (Wasmeier et al.,
2006), and it also is involved in melanosome transport in
Xenopus melanophores (Park et al., 2007). However, the mo-
lecular mechanism by which Rab32/38 regulate tyrosinase
and/or Tyrp1 transport remains completely unknown, and
no specific effector molecules for Rab32/38 have ever been
identified in melanocytes. Because Rab32 can compensate
for the dysfunction of Rab38 in melan-chocolate (cht) cell lines
(Wasmeier et al., 2006), a putative effector molecule(s) for
Rab38 in melanocytes must interact with both Rab32 and
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Rab38, the same as rabphilin interacts with both Rab3A and
Rab27A (Kuroda et al., 2002; Fukuda, 2003; Fukuda et al.,
2004), both of which regulate docking of hormone granules
to the plasma membrane in neuroendocrine PC12 cells
(Tsuboi and Fukuda, 2006). Wang et al. (2008) very recently
reported that vacuolar protein sorting 9 (VPS9)-ankyrin-
repeat protein (Varp; official gene symbol in National Center
for Biotechnology Information: Ankrd27), originally identi-
fied as a guanine nucleotide exchange factor (GEF) for Rab21
(Zhang et al., 2006), interacted with Rab38 in COS-7 cells by
overexpression study. However, neither Rab binding speci-
ficity of Varp (e.g., binding of Rab32) nor functional data on
Varp in melanocytes was included in this report.
In this study, we screened for a dual effector for Rab32 and
Rab38 and identified Varp as a Rab32- and Rab38-specific
binding protein. We showed by deletion analysis that
Rab32/38 specifically interacts with the first ankyrin repeat
(referred to as ANKR1 below) and does not interact with the
VPS9 domain, a putative Rab5 GEF domain (Horiuchi et al.,
1997; Carney et al., 2006). We further showed that small
interfering RNA (siRNA)-mediated knockdown of endoge-
nous Varp or expression of the Rab32/38-binding domain
(i.e., ANKR1) in cultured melanocytes induced disappear-
ance of Tyrp1 signals from the cytoplasm. Based on our
findings, we discuss the possible function of Varp in Tyrp1
trafficking to melanosomes in melanocytes.
MATERIALS AND METHODS
Materials
Horseradish peroxidase (HRP)-conjugated anti-FLAG tag (M2) mouse mono-
clonal antibody (mAb) and anti-FLAG tag antibody-conjugated agarose were
obtained from Sigma-Aldrich (St. Louis, MO). HRP-conjugated anti-T7 tag
mouse mAb and anti-T7 tag antibody-conjugated agarose were purchased
from Merck Biosciences Novagen (Darmstadt, Germany). Anti-Tyrp1 mouse
mAb (Ta99) was from ID Labs (London, ON, Canada). Anti-Tyrp1 goat
polyclonal antibody and anti-actin goat polyclonal antibody were from Santa
Cruz Biotechnology (Santa Cruz, CA). Anti-Pmel17 mouse mAb (HMB45)
and Alexa 488/594/633-conjugated anti-mouse immunoglobulin G (IgG) goat
antibody were from Dako North America (Carpinteria, CA) and Invitrogen
(Carlsbad, CA), respectively. Anti-DsRed rabbit polyclonal antibody was
from MBL (Nagoya, Japan). The lysosomal protease inhibitors E64d and
pepstatin A and the proteasome inhibitor MG132 were from Peptide Institute
(Osaka, Japan). All other reagents used in this study were analytical grade or
the highest grade commercially available.
Yeast Two-Hybrid Screening
cDNAs of the GTP-fixed mutants Rab32(Q83L)Cys and Rab38(Q69L)Cys
were subcloned into the pGBD-C1 vector as described previously (Fukuda
et al., 2008). Each Rab construct was used to screen oligo(dT)-primed mouse
testis and mouse embryo mixed cDNA libraries according to the manufac-
turer’s instructions (Clontech, Mountain View, CA), and 1  108 colonies
were investigated. After DNA sequencing and database searching, the Rab
binding specificity of positive clones was further investigated by using the
panel of 60 different putatively GTP-locked Rabs (simply referred to as
GTP-locked Rabs below) essentially as described previously (Itoh et al., 2006).
The yeast strain, medium, culture conditions, and transformation protocol
used are described in James et al. (1996). The materials used for the two-
Figure 1. Rab binding specificity of Varp as revealed
by yeast two-hybrid panels. (A) Specific interaction of
Varp-Full with the GTP-fixed form of Rab32 and Rab38,
and of Cep63 with the GTP-fixed form of Rab32. Yeast
cells containing pGBD plasmid expressing GTP-locked
Rab protein (positions indicated in the left panels) and
pAct2 plasmid expressing Varp (or Cep63) protein were
streaked on SC-AHLW and incubated at 30°C. Positive
patches are boxed. (B) Specific interaction of Varp-Full
and Varp-NVPS9 with the nucleotide-free form of
Rab21. Yeast cells containing pGBD plasmid expressing
Varp protein and pGAD plasmid expressing nucleoti-
de-free Rab (positions indicated in the left panels) were
streaked on SC-AHLW and incubated at 30°C. Positive
patches are boxed. (C) Schematic representation of Varp
and its truncated mutant Varp-NVPS9 used in A
and B. Varp contains an N-terminal VPS9 domain and
C-terminal tandem ankyrin repeats (named ANKR1
and ANKR2).
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hybrid assay in this study were as follows: yeast strain pJ69-4A; plasmid
pGAD-C1 (or pAct2) for expression of activating domain fusion protein;
plasmid pGBD-C1 for expression of DNA-binding domain fusion protein;
and a synthetic complete medium lacking adenine, histidine, leucine, and
tryptophan (SC-AHLW, 0.67% yeast nitrogen base without amino acids, 2%
glucose, 2% Bacto agar, 0.01% uracil, 0.0125% lysine, and 0.01% methionine)
for the selection medium.
Plasmid Constructions
pGBD-C1 vector harboring GTP-fixed mutants of Rab1-43 lacking the
C-terminal geranylgeranylation site was prepared as described previously
(Itoh et al., 2006; Fukuda et al., 2008). Putatively nucleotide-free and/or
GDP-locked mutants of Rab (simply referred to as nucleotide free Rabs
below) were produced by replacement of a conserved threonine (or serine)
with asparagine by conventional or two-step polymerase chain reaction (PCR)
techniques as described previously (Fukuda et al., 1995, 2008). The sequences
of the mutagenic oligonucleotides used are available from the authors on
request. The following nucleotide-free Rab mutants were used in this study:
Rab1A(S25N), Rab1B(S22N), Rab2A(S20N), Rab2B(S20N), Rab3A(T36N),
Rab3B(T36N), Rab3C(T44N), Rab3D(T36N), Rab4A(S27N), Rab4B(S22N),
Rab5A(S34N), Rab5B(S48N), Rab5C(S35N), Rab6A(T27N), Rab6B(T27N),
Rab6C(T27N), Rab7(T22N), Rab8A(T22N), Rab8B(T22N), Rab9A(S21N),
Rab9B(S21N), Rab10(T23N), Rab11A(S25N), Rab11B(S25N), Rab12(T55N),
Rab13(T22N), Rab14(S25N), Rab15(T22N), Rab17(T33N), Rab18(S22N),
Rab19(T31N), Rab20(T19N), Rab21(T31N), Rab22A(S19N), Rab22B(S19N),
Rab23(S23N), Rab24(T21N), Rab25(T26N), Rab26(S81N), Rab27A(T23N),
Rab27B(T23N), Rab28(T26N), Rab29(T21N), Rab30(T23N), Rab32(T37N),
Rab33A(T50N), Rab33B(T47N), Rab34(T66N), Rab35(S22N), Rab36(T71N),
Rab37(T43N), Rab38(T23N), Rab39A(S22N), Rab39B(S22N), Rab40A(S28N),
Rab40B(G28N), Rab40C(G28N), Rab41(T30N), Rab42(T22N), and Rab43(T23N).
Because Rab40B and Rab40C lack the conserved threonine (or serine) residue and
its position is occupied by glycine, we used Rab40B(G28N) and Rab40C(G28N),
respectively, as the nucleotide-free mutants in this study. The nucleotide-free Rab
mutants were subcloned into the pGAD-C1 vector.
cDNA of mouse Varp was amplified from Marathon-Ready mouse brain
cDNA (Clontech) by PCR using the following oligonucleotides with a restric-
tion enzyme site (underlined) or a stop codon (bold) as described previously
(Fukuda et al., 1999): 5-GGATCCATGGCTCTATATGATGAAGA-3 (Met
primer, sense) and 5-CTAAGACTGAGGAACACTCG-3 (stop primer, anti-
sense). The nucleotide sequence reported in this article has been submitted to
the GenBank/EBI Data Bank with an accession AB455262. Truncated mutants
of Varp (see Figure 3A) were prepared by conventional PCR using specific
pairs of oligonucleotides, and their sequences are available from the authors
on request. Varp-Full contains amino acid residues 1-1048 of Varp; Varp-N,
residues 1-250; Varp-NVPS9, residues 1-450; Varp-VPS9, residues 251-450;
Varp-ANKR1ANKR2, residues 451-1048; Varp-ANKR1, residues 451-729;
Varp-ANKR2, residues 730-1048; Varp-ANKR1-N, residues 451-600; and
Varp-ANKR1-C, residues 601-729. These truncated Varp mutants were sub-
cloned into the pGAD-C1, pGBD-C1, pGEX-4T-3 (GE Healthcare, Chalfont
St. Giles, Buckinghamshire, United Kingdom), pmStrawberry-C1 (pStr-C1)
(Shaner et al., 2004), and/or pEF-T7 tag expression vector (Fukuda et al.,
1999). A mutant Varp that lacks a second repeat (amino acid residues
495-527) in the ANKR1 (named ; see Figure 3A) was similarly prepared
by PCR using a specific pair of oligonucleotides, and their sequences are
also available from us on request. The mutant Varp- (or ANKR1-) was
subcloned into the pGAD-C1 and/or pStr-C1 vectors. pEF-FLAG-Rab32 and
-Rab38 were prepared as described previously (Fukuda, 2003).
The following pairs of nucleotides with a 19-base target site (site 1 in bold) and
a nine-base loop (in italics) were used to generate short hairpin RNA (shRNA)
expression plasmids against mouse Varp mRNA: Varp shRNA() primer
(5-GATCCAAGGAAACAGGATTAAGCTAGTTCAAGAGACTAGCTTAAT-
CCTGTTTCCTTTTTTTTGGAAA-3) and Varp shRNA() primer (5-AG-
CTTTTCCAAAAAAGGAAACAGGATTAAGCTAGTCTCTTGAACTAGCTT-
AATCCTGTTTCCG-3). The pairs of nucleotides were mixed, denatured at 94°C
for 2 min, annealed at 72°C for 1 min, gradually cooled to 4°C for 2 h, and then
subcloned into the BamHI/HindIII site of the pSilencer 2.1-U6 neo (Ambion,
Austin, TX), which expresses shRNA under the control of the mouse U6 pro-
moter. The plasmid obtained was referred to as pSilencer-Varp site 1 (unless
otherwise stated, pSilencer-Varp means pSilencer-Varp site 1. pSilencer-Varp site
2 (target site: 5-CAGACTGAAGGAAACACCA-3) was similarly constructed.
The knockdown efficiency of pSilencer-Varp site 1/2 was evaluated in COS-7
cells (see Figure 6A, right) as described previously (Kuroda and Fukuda, 2004).
Antibody Production
Glutathione transferase (GST)-Varp-N (amino acid residues 1-250), GST-
Rab32, and GST-Rab38 were prepared by standard protocols (Kuroda and
Fukuda, 2005). Japanese White rabbits were immunized with the purified
GST-Varp-N, GST-Rab32, or GST-Rab38, and specific antibodies were affinity
purified by exposure to antigen-bound Affi-Gel 10 beads (Bio-Rad Laborato-
ries, Hercules, CA) as described previously (Fukuda and Mikoshiba, 1999).
Immunofluorescence Analysis
The immortal mouse melanocyte cell line melan-a, derived from a black
mouse (generous gift of Dorothy C. Bennett, St. George’s Hospital Medical
School, London, United Kingdom) was cultured on glass-bottomed dishes
(35-mm dish; MatTek, Ashland, MA) (Bennett et al., 1987; Kuroda et al., 2003).
Transfection of pStr-C1-Varp, pEGFP-C1-Rab, pSilencer-Varp, or a control
vector (pStr-C1, pEGFP-C1, or pSilencer alone, respectively) was achieved by
using FuGENE 6 (Roche Molecular Biochemicals, Mannheim, Germany) ac-
cording to the manufacturer’s instructions. Two days after transfection, cells
were fixed in 4% paraformaldehyde, permeabilized with 0.3% Triton X-100,
stained with anti-Tyrp1 mouse mAb (1/100 dilution) or anti-Pmel17 mouse
mAb (1/100 dilution), and then visualized with anti-mouse Alexa Fluor
488/594/633 IgG, and examined for fluorescence with a confocal fluorescence
microscope (FluoView; Olympus, Tokyo, Japan) as described previously
(Kuroda et al., 2003). Exposure to the proteasome inhibitor (10 M MG132) or
lysosomal protease inhibitors (10 g/ml E64d and 10 g/ml pepstatin A) was
performed 6 h before fixation. The images were processed with Photoshop
software (CS3; Adobe Systems, Mountain View, CA). To quantitatively mea-
Figure 2. Varp interacts with Rab32 and Rab38 in mammalian
cells. (A) Varp interacts with Rab32 and Rab38, but not with
Rab27A, in the presence of 0.5 mM guanosine 5-O-(3-thio)triphos-
phate (GTPS). T7-tagged Varp-Full and FLAG-tagged Rab27A/
32/38 were expressed in COS-7 cells, and their associations were
analyzed by coimmunoprecipitation assay using anti-FLAG tag an-
tibody-conjugated agarose beads as described previously (Fukuda
and Kanno, 2005). Coimmunoprecipitated T7-Varp-Full (middle)
and immunoprecipitated FLAG-Rabs (bottom) were detected with
HRP-conjugated anti-T7 tag antibody and HRP-conjugated anti-
FLAG tag antibody, respectively. Input means 1/80 volume of the
reaction mixture used for immunoprecipitation (top). (B) GTP-de-
pendent interaction between Varp and Rab38. Binding assay was
performed in the presence of 0.5 mM GTPS (lane 1) or 1 mM GDP
(lane 2) as described in A. (C) Direct interaction between Varp and
Rab38. Agarose beads coupled with T7-Varp (arrow) were incu-
bated with purified GST-Rab38 (lane 4, closed arrowhead) or GST
alone (lane 3, open arrowhead), and bound proteins were detected
with Coomassie Brilliant Blue R-250. Input means 1/25 volume of
the reaction mixture (lanes 1 and 2). (D) Endogenous interaction
between Varp and Rab32/38 in melan-a cells. The positions of the
molecular mass markers ( 103) are shown on the left.
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sure Tyrp1 and Pmel17 signals, the images of the green fluorescent protein
(GFP)-expressing cells (i.e., Varp shRNA-expressing cells) or the Str-Varp–
expressing cells were captured at random (n  50 from three independent
dishes) with the confocal microscope, and fluorescent signals of Tyrp1 or
Pmel17 were quantified with MetaMorph software (Molecular Devices,
Sunnyvale, CA).
Binding Assays
Plasmids (pEF-T7-Varp and pEF-FLAG-Rab) were transfected into COS-7
cells (3  105 cells/6-cm dish, the day before transfection) by using Lipo-
fectamine Plus (Invitrogen) according to the manufacturer’s notes. Coimmu-
noprecipitation assays using anti-FLAG tag antibody-conjugated agarose
were performed as described previously (Fukuda and Kanno, 2005). Direct
interaction between T7-Varp and GST-Rab32/38 and endogenous interaction
between Varp and Rab32/38 also were performed as described previously
(Fukuda and Kanno, 2005).
siRNA-mediated Knockdown of Varp in Melan-a Cells
siRNA against the site 1 (see above) of mouse Varp (5-GGAAACAG-
GAUUAAGCUAGdTdT-3; sense) was chemically synthesized by Nippon
EGT (Toyama, Japan). Transfection of the Varp siRNA or control siRNA into
melan-a cells was achieved by using Lipofectamine RNAiMax (Invitrogen)
according to the manufacturer’s instructions. At 48 h after transfection, the
cells were harvested and lysed. An aliquot of total cell lysates was analyzed
by immunoblotting using anti-Varp antibody, anti-Tyrp1 antibody, and anti-
actin antibody. Immunoreactive bands were visualized by enhanced chemi-
luminescence.
Melanin Assay
Melanin assay was performed essentially as described previously (Wasmeier
et al., 2006). In brief, melan-a cells were solubilized in 50 mM HEPES-KOH,
pH 7.2, 150 mM NaCl, 1% Triton X-100, and protease inhibitors. Pigment was
pelleted by centrifugation at 17,400  g for 20 min at 4°C, and the pellet was
allowed to dissolve in 1 M NaOH/10% dimethyl sulfoxide for 30 min at
100°C. Melanin content was measured as optical density at 490 nm and
normalized to protein content.
RESULTS
Identification of Varp as a Rab32/38-specific Binding
Protein
To identify a Rab32/38-specific effector molecule(s) that
functions in melanocytes, we screened mouse cDNA librar-
ies by yeast two-hybrid assay by using the GTP-fixed form
of Rab32 and Rab38 as bait (see Materials and Methods for
details). Although no positive clone was obtained for Rab38,
we succeeded in obtaining two positive clones for Rab32, a
Varp clone and a centrosomal protein 63 (Cep63) clone.
Their Rab binding specificity was further investigated by a
yeast two-hybrid assay with a panel of 60 different GTP-
locked Rabs (Itoh et al., 2006; Fukuda et al., 2008). As shown
in Figure 1A (boxed), Varp specifically interacted with two
phylogenetically related Rabs, Rab32 and Rab38, whereas
Cep63 recognized Rab32 alone. However, because the inter-
action between Cep63 and Rab32 was not observed in mam-
malian cells (data not shown), we concluded that the Cep63-
Rab32 interaction observed in yeast cells was a false positive.
By contrast, Varp did interact with both Rab32 and Rab38
(Figure 2A, middle, lanes 2 and 3) in COS-7 cells, but not
with Rab27A (another melnaosome-resident Rab). The inter-
action between Varp and Rab32/38 is GTP-dependent (Fig-
ure 2B and Supplemental Figure S1A; Wang et al., 2008) and
direct (lane 4 in Figure 2C and Supplemental Figure S1B).
We further confirmed the endogenous interaction between
Varp and Rab32/38 in melan-a cells by coimmunoprecipi-
tation assay using anti-Varp specific antibody (Figure 2D).
We therefore focused on Varp as a candidate Rab32/38-
specific effector for subsequent analysis.
Figure 3. Mapping of the Rab32/38-binding
site in Varp. (A) Schematic representation of
Varp and its truncated mutants used in this
study. Varp contains an N-terminal VPS9 do-
main and C-terminal tandem ankyrin repeats
(named ANKR1 and ANKR2). (B) ANKR1
functions as the Rab32/38-binding domain of
Varp. (C) A Rab32/38-binding-defective mu-
tant of Varp ANKR1 (named ANKR1-) that
lacks a second repeat in the ANKR1 (see (A)).
Yeast cells containing pGAD plasmid express-
ing Varp mutants and pGBD plasmid express-
ing GTP-locked Rab32 (left) or Rab38 (right)
were streaked on SC-LW (top) and SC-AHLW
(bottom) and incubated at 30°C.
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Figure 4. Colocalization of Varp and Rab38 in
melanocytes. Melan-a cells transiently express-
ing GFP-Rab38 and Str-Varp (A–D), GFP-Rab38
and Str-Varp-NVPS9 (E–H), GFP-Rab38 and
Str-Varp-ANKR1 (I–L), or GFP-Rab38 and Str-
Varp- (M–P). Note that Varp-Full and Varp-
ANKR1, but not Varp-NVPS9 or Varp-, co-
localized well with Rab38 (yellow in C and K).
The insets show magnified views of the boxed
area. Only a few Varp- and Rab38-positive
signals colocalized with melanosomes (pseudo-
colored in blue; arrowheads) in the perinu-
clear region (but see Supplemental Figure S3;
colocalization between Varp and melano-
somes were observed in the cell periphery).
Bars, 20 m.
Figure 5. (A and B) Effect of the Varp shRNA
on Tyrp1 staining and distribution in melan-a
cells. Melan-a cells were transfected with a con-
trol vector (a–d) or Varp shRNA expression
vector (e–h) together with the GFP expression
vector as a transfection marker. Cells were im-
munostained with anti-Tyrp1 antibody (A) or
anti-Pmel17 antibody (B) and visualized with
Alexa Fluor 594 secondary antibody. Bright-field
images show the melanosome distribution in the
cells. Bars, 20 m. Note that siRNA-mediated
knockdown of Varp dramatically reduced Tyrp1-
staining (arrowheads in A) but did not reduce
Pmel17-staining, in melan-a cells.
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ANKR1 Domain of Varp Functions as a Rab32/38-binding
Domain
Mouse Varp consists of 1048 amino acids and contains an
N-terminal single VPS9 domain and C-terminal two ankyrin
repeat domains (named the ANKR1 domain and ANKR2
domain) (Figure 3A). To identify the Rab32/38-binding site
of Varp, a series of deletion mutants of Varp was produced
(Figure 3A) and their binding to Rab32/38 was investigated
by the two-hybrid assay as described above (Figure 3B). The
results indicated that the ANKR1 domain alone is necessary
and sufficient for binding of Rab32 and Rab38. Although the
VPS9 domain of Varp has recently been shown to interact
with the GDP-bound form of Rab21 (Wang et al., 2008) and
to exhibit Rab21 GEF activity (Zhang et al., 2006), neither
Rab32 nor Rab38 bound the N-terminal VPS9 domain under
our experimental conditions. Consistent with the report by
Wang et al. (2008), Varp also interacted with the nucleotide-
free (i.e., constitutive negative) mutant of Rab21, but not
with any of the other 59 nucleotide-free Rabs, including
Rab32 and Rab38 (Figure 1B, boxed). We therefore con-
cluded that Varp interacts with the GDP-bound/nucleotide-
free form of Rab21 via the N-terminal VPS9 domain and
with the GTP-bound form of Rab32/38 via the C-terminal
ANKR1 domain.
Colocalization between Varp and Rab32/38 in
Melanocytes
We next attempted to determine whether Varp colocalizes
with Rab32/38 in cultured melanocytes. We initially at-
tempted to determine the subcellular localization of en-
dogenous Varp by using anti-Varp specific antibody, but
because it was impossible to use the antibody for an im-
munofluorescence analysis, we were unable to determine
the localization of endogenous Varp in melan-a cells. To
overcome this problem, GFP-tagged Rab38 (or Rab32) and
monomeric strawberry (Str)-tagged Varp were coexpressed
in melan-a cells, and their subcellular localization was ana-
lyzed by confocal fluorescence microscopy. Consistent with
a previous observation (Wasmeier et al., 2006), GFP-Rab32
and GFP-Rab38 were targeted to melanosomes in addition
to the perinuclear region (Figure 4A and Supplemental Fig-
ure S2A). It should be noted that Varp overlapped well with
Rab32/38 (yellow dots in Figure 4C and Supplemental Fig-
ure S2C) and Tyrp1 (Supplemental Figure S3, A, B, and D),
whereas colocalization of Varp with melanosomes is limited
in the peripheral region of the cell (Supplemental Figure S3,
A, C, and E). This colocalization must be mediated by the
C-terminal ANKR1 domain of Varp, because the ANKR1
domain alone is sufficient to cause colocalization with
Rab32/38 (Figure 4, I–L, and Supplemental Figure S2, I–L),
and no colocalization was observed between Rab32/38 and
the N-terminal half of Varp, which contains the VPS9 do-
main (Figure 4, E–H, and Supplemental Figure S2, E–H). To
further determine whether Rab32/38 –Varp interaction is
required for their colocalization in melanocytes, we produced a
Rab32/38-binding-defective mutant of Varp (named Varp-;
also see Figure 3C). As expected, no colocalization between
Rab32/38 and Varp- was observed in melan-a cells (Figure
4, M–P, and Supplemental Figure S2, M–P). We therefore
concluded that colocalization between Rab32/38 and Varp
in melanocytes is mediated by a direct interaction between
Rab32/38 and Varp.
Functional Involvement of Varp in Tyrp1 Trafficking in
Melanocytes
Finally, because Varp is endogenously expressed in melan-a
cells (Figure 2D) and Rab32/38 have been shown to be
Figure 6. Reduced expression of Tyrp1 in Varp-deficient melano-
cytes. (A) Reduced expression of Tyrp1 and Varp in siVarp-treated
melanocytes as revealed by immunoblotting (left panel). Cell lysates
of melan-a cells treated with either siVarp or control siRNA (20
g) were subjected to 10% SDS-polyacrylamide gel electrophoresis
(PAGE) followed by immunoblotting with anti-Varp specific anti-
body (1/100 dilution), anti-Tyrp1 antibody (1/200 dilution), and
anti-actin antibody (1/400 dilution). Right, efficiency and specificity
of shRNA targeted against Varp were shown. Str-Varp was ex-
pressed in COS-7 cells together with Varp shRNA or a control
vector. Cell lysates were subjected to 10% SDS-PAGE followed by
immunoblotting with anti-DsRed antibody (1/100 dilution) and
anti-actin antibody. The positions of the molecular mass markers (
103) are shown on the left. (B) Reduced expression of Tyrp1 in Varp
shRNA-expressing melanocytes as revealed by immunofluores-
cence analysis. Note that expression of Tyrp1 in Varp-deficient cells
dramatically reduced, whereas expression of Pmel17 had no effect.
The bars represent the means  SE of data from three independent
dishes (n  50). **p 	 0.01, Student’s unpaired t test. (C) Reduced
melanin content in Varp siRNA-expressing melanocytes. Melan-a
cells expressing Varp siRNA (right) and control siRNA (left) were
harvested, and their melanin content was assayed by measuring
optical density at 490 nm. The bars represent the means  SD of
data from triplicate experiments. **p 	 0.01, Student’s unpaired
t test.
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involved in the trafficking of melanogenic enzymes (Wasmeier
et al., 2006), we investigated the effect of knockdown of
endogenous Varp on trafficking of Tyrp1 by expressing
specific shRNA against mouse Varp (Figure 5). As shown
in Figures 5A and 6B, there was a dramatic reduction in
Tyrp1 signals in the Varp-knockdown cells (arrowhead),
especially at the cell periphery, without affecting melano-
some distribution, whereas no change in the level of
Tyrp1 signals was observed in control GFP-expressing
(i.e., control pSilencer-expressing) cells. By contrast, ex-
pression of Pmel17/GP100, a premelanosomal integral
membrane protein (Theos et al., 2005), was unaffected by
the knockdown of Varp (Figure 5B). Because similar re-
sults were obtained for the independent shRNA (site 2;
Supplemental Figure S4), the observed effects (Figure 5A)
are unlikely to be attributable to an off target effect. Re-
duced expression of Varp and Tyrp1 was further con-
firmed by immunoblot analysis (Figure 6A, left). Because
there did not seem to be any difference in the melanin
content of the Varp-knockdown cells and control cells
under a light microscope when they were examined (Fig-
ure 5), we harvested the cells, which had been treated
with either Varp siRNA or control siRNA for 48 h, and we
compared their melanin content by measuring optical
density at 490 nm. As shown in Figure 6C, there was a
clear reduction in the melanin content of the Varp siRNA-
treated cells, in comparison with the control siRNA-
treated cells.
To further investigate the involvement of Varp in
Rab32/38-dependent Tyrp1 trafficking, we used the Rab32/
38-binding domain of Varp (i.e., ANKR1) as a dominant-neg-
ative construct in an attempt to block the function of Rab32/38
by interrupting the interaction between endogenous Rab32/38
and Varp. As expected, expression of the ANKR1 domain
similarly caused a drastic reduction in Tyrp1 signals, whereas
expression of the N-terminal VPS9 domain (NVPS9) or the
control Rab32/38-binding-defective ANKR1- mutant had vir-
tually no effect on Tyrp1 staining or its distribution (Figures
7A, 8, A and B, and Supplemental Figure S5). The same as in
Varp-knockdown cells, expression of Pmel17 was unaffected in
ANKR1-expressing cells (Figures 7B and 8B). Therefore, Varp
is likely to be involved together with Rab32/38 in the Tyrp1
trafficking in melanocytes.
DISCUSSION
It has previously been reported that Rab32 and Rab38 re-
dundantly regulate the trafficking of melanogenic enzymes
to melanosomes (Wasmeier et al., 2006); however, no Rab32/
38-specific effector that functions in melanocytes had ever
been identified. In the present study, we succeeded in iden-
tifying Varp as a Rab32/38-specific binding protein. While
this manuscript was being prepared for publication, Varp
was reported to interact with Rab38 in COS-7 cells by an-
other group (Wang et al., 2008). The present study, however,
considerably extends the study by Wang et al. (2008) in the
Figure 7. Effect of the Varp-ANKR1 domain on Tyrp1 staining and distribution in melan-a cells. Melan-a cells transiently expressing
Str-Varp-ANKR1 (a–d), Str-Varp-NVPS9 (e–h), or control Str alone (i–l) were immunostained with anti-Tyrp1 antibody (A) or anti-Pmel17
antibody (B) and visualized with Alexa Fluor 488 secondary antibody. Bright-field images show the melanosome distribution in the cells.
Note that expression of Varp-ANKR1, but not of Varp-NVPS9, caused the dramatic reduction in Tyrp1 signals (A), whereas no effect was
observed for Pmel17 signals (B). Bars, 20 m.
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following respects. First, we precisely determined the Rab
binding specificity of Varp by a yeast two-hybrid assay
using a panel of 60 different GTP-locked Rabs and demon-
strated that Varp specifically interacts with the GTP-locked
Rab32 and Rab38, but not with any of the other 58 Rabs
tested (Figure 1A), via the ANKR1 domain. Second, we
demonstrated that Varp (or Varp-Rab32/38 complex) is en-
dogenously expressed in melan-a cells (Figures 2D and 6A)
and that GFP-Rab32/38 and Str-Varp are well colocalized in
these cells (Figure 4 and Supplemental Figure S2). Third, we
for the very first time demonstrated that knockdown of
endogenous Varp in melan-a cells by a specific shRNA or
expression of the Rab32/38-binding domain of Varp in
melan-a cells causes a dramatic reduction in endogenous
Tyrp1 signals (Figures 5A, 6B, 7A, and 8B), but no reduction
in Pmel17 signals (Figures 5B, 6B, 7B, and 8B), strongly
suggesting that Varp together with Rab32/38 is involved in
trafficking of Tyrp1 to melanosomes in melanocytes.
Because it has recently been proposed that Tyrp1 is trans-
ported to melanosomes through endosomes (Raposo and
Marks, 2007), it would be fascinating if, in addition to
Rab32/38, endosomal Rab21, which is activated by Varp
(Zhang et al., 2006), is also involved in Tyrp1 trafficking in
melanocytes. In the present study, however, we were unable
to obtain any evidence that Rab21 is involved in Tyrp1
trafficking, first, because expression of the N-terminal VPS9
domain of Varp had no effect on Tyrp1 staining or its dis-
tribution (Figure 7A, e–h); and, second, expression of con-
stitutive active/negative mutants of Rab21 or specific Rab21
shRNA had no effect on Tyrp1 expression (Supplemental
Figure S6). These observations collectively indicate that
Rab21 is unlikely to be directly involved in Tyrp1 trafficking
in melanocytes.
What is the function of Varp in the melanosomal localiza-
tion of Tyrp1 in melanocytes? Because melanogenic en-
zymes have recently been suggested to be mistargeted and
degraded in Rab32/38-deficient melanocytes (Wasmeier
et al., 2006), the most likely function of Varp is to control
trafficking of Tyrp1 (e.g., transport from an endoplasmic
reticulum [ER] to the Golgi, transport from endosomes or
the trans-Golgi network, tethering, docking, and/or fusion
of Tyrp1-containing vesicles to melanosomes) together with
Rab32/38. In the absence of Varp, Tyrp1 is not correctly
targeted to melanosomes, and mistargeted Tyrp1 (or un-
transported Tyrp1 in the ER) may be ubiquitinated (Ando
et al., 2004, 2007; Kageyama et al., 2004) and degraded by
proteasomes (e.g., ER-associated degradation), because our
preliminary experiments showed that treatment of Varp-
knockdown cells (or GFP-ANKR1–expressing cells) with a
proteasome inhibitor, MG132, but not with lysosomal pro-
tease inhibitors (E64d and pepstatin A), restored Tyrp1
staining (Supplemental Figure S7Af). However, treatment of
cells with proteasome inhibitors also affected the morphol-
ogy of the cell (i.e., change into extended and filamentous
shape), which precludes us to determine the exact localiza-
tion of mistargeted proteins by immunofluorescence analy-
sis (Supplemental Figure S7A, e–h). Further work is neces-
sary to determine the exact mechanism of reduction in Tyrp1
levels in the absence of Varp.
In summary, we have identified Varp as a Rab32/38-
specific binding protein in melanocytes and demonstrated
that knockdown of endogenous Varp or expression of a
dominant-negative construct (i.e., ANKR1) in melanocytes
greatly attenuates the signals of a melanogenic enzyme,
Tyrp1. So far as we know, Varp is the first candidate for a
downstream target of Rab32/38 in melanocytes that is re-
quired for proper melanosomal localization of Tyrp1.
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Ménasché, G., Pastural, E., Feldmann, J., Certain, S., Ersoy, F., Dupuis, S.,
Wulffraat, N., Bianchi, D., Fischer, A., Le Deist, F., and de Saint Basile, G.
(2000). Mutations in RAB27A cause Griscelli syndrome associated with hae-
mophagocytic syndrome. Nat. Genet. 25, 173–176.
Park, M., Serpinskaya, A. S., Papalopulu, N., and Gelfand, V. I. (2007). Rab32
regulates melanosome transport in Xenopus melanophores by protein kinase
A recruitment. Curr. Biol. 17, 2030–2034.
Pfeffer, S. R. (2001). Rab GTPases: specifying and deciphering organelle iden-
tity and function. Trends Cell Biol. 11, 487–491.
Raposo, G., and Marks, M. S. (2007). Melanosomes: dark organelles enlighten
endosomal membrane transport. Nat. Rev. Mol. Cell Biol. 8, 786–797.
Schwartz, S. L., Cao, C., Pylypenko, O., Rak, A., and Wandinger-Ness, A.
(2007). Rab GTPases at a glance. J. Cell Sci. 120, 3905–3910.
Shaner, N. C., Campbell, R. E., Steinbach, P. A., Giepmans, B.N.G., Palmer,
A. E., and Tsien, R. Y. (2004). Improved monomeric red, orange and yellow
fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat.
Biotechnol. 22, 1567–1572.
Theos, A. C., Truschel, S. T., Raposo, G., and Marks, M. S. (2005). The Silver
locus product Pmel17/gp100/Silv/ME 20, controversial in name and in func-
tion. Pigment Cell Res. 18, 322–336.
Tsuboi, T., and Fukuda, M. (2006). Rab3A and Rab27A cooperatively regulate
the docking step of dense-core vesicle exocytosis in PC12 cells. J. Cell Sci. 119,
2196–2203.
Wang, F., Zhang, H., Zhang, X., Wang, Y., Ren, F., Zhang, X., Zhai, Y., and
Chang, Z. (2008). Varp interacts with Rab38 and functions as its potential
effector. Biochem. Biophys. Res. Commun. 372, 162–167.
Wasmeier, C., Romao, M., Plowright, L., Bennett, D. C., Raposo, G., and
Seabra, M. C. (2006). Rab38 and Rab32 control post-Golgi trafficking of mel-
anogenic enzymes. J. Cell Biol. 175, 271–281.
Wilson, S. M., Yip, R., Swing, D. A., O’Sullivan, T. N., Zhang, Y., Novak, E. K.,
Swank, R. T., Russell, L. B., Copeland, N. G., and Jenkins, N. A. (2000). A
mutation in Rab27a causes the vesicle transport defects observed in ashen
mice. Proc. Natl. Acad. Sci. USA 97, 7933–7938.
Wu, X. S., Rao, K., Zhang, H., Wang, F., Sellers, J. R., Matesic, L. E., Copeland,
N. G., Jenkins, N. A., and Hammer, J. A., III. (2002). Identification of an
organelle receptor for myosin-Va. Nat. Cell Biol. 4, 271–278.
Zerial, M., and McBride, H. (2001). Rab proteins as membrane organizers.
Nat. Rev. Mol. Cell Biol. 2, 107–117.
Zhang, X., He, X., Fu, X. Y., and Chang, Z. (2006). Varp is a Rab21 guanine
nucleotide exchange factor and regulates endosome dynamics. J. Cell Sci. 119,
1053–1062.
K. Tamura et al.
Molecular Biology of the Cell2908
